{"pmid":32420954,"title":"Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.","text":["Smell and taste dysfunction during the COVID-19 outbreak: a preliminary report.","In late December 2019, in Wuhan (China), health authorities reported several clusters of pneumo- nia of unknown cause, subsequently attributed to a novel coronavirus, identified as Severe Acute Respiratory Syndrome-Coronavirus 2. Anosmia and dysgeusia have been reported as particular symptoms.4,5 Notably, these sensory symptoms seem to have a peculiar trend, such as usually precede the onset of respiratory symp- toms. So, they have been defined as \"sentinel\" symptoms. We presented a series of COVID-19 patients. Anos- mia and dysgeusia frequently preceded respiratory complaints. Anosmia and dysgeusia seem to be short-lived and self-resolving in COVID-19, thus a neurotoxic effect swiftly disappearing and/or cytopathic damage could be hypothesized similarly to other viral infections.","Acta Biomed","Gelardi, Matteo","Trecca, Eleonora","Cassano, Michele","Ciprandi, Giorgio","32420954"],"abstract":["In late December 2019, in Wuhan (China), health authorities reported several clusters of pneumo- nia of unknown cause, subsequently attributed to a novel coronavirus, identified as Severe Acute Respiratory Syndrome-Coronavirus 2. Anosmia and dysgeusia have been reported as particular symptoms.4,5 Notably, these sensory symptoms seem to have a peculiar trend, such as usually precede the onset of respiratory symp- toms. So, they have been defined as \"sentinel\" symptoms. We presented a series of COVID-19 patients. Anos- mia and dysgeusia frequently preceded respiratory complaints. Anosmia and dysgeusia seem to be short-lived and self-resolving in COVID-19, thus a neurotoxic effect swiftly disappearing and/or cytopathic damage could be hypothesized similarly to other viral infections."],"journal":"Acta Biomed","authors":["Gelardi, Matteo","Trecca, Eleonora","Cassano, Michele","Ciprandi, Giorgio"],"date":"2020-05-19T11:00:00Z","year":2020,"_id":"32420954","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.23750/abm.v91i2.9524","locations":["Wuhan","China","dysgeusia"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1667254896694394880,"score":9.490897,"similar":[{"pmid":32352450,"title":"Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.","text":["Sniffing out the evidence; It's now time for public health bodies recognize the link between COVID-19 and smell and taste disturbance.","Since the outbreak of the pandemic, anecdotal observations have been accumulating rapidly that sudden anosmia and dysgeusia are peculiar symptoms associated with the COVID-19 infection. Prof C. Hopkins, as President of British Rhinological Society, published a letter describing \"the loss of sense of smell as a marker of COVID-19 infection\" and proposed that adults presenting with anosmia but no other symptoms should self-isolate for seven days. The Hopkins team published the first case report and case series as well as other evidence that isolated sudden onset anosmia (ISOA), should be considered highly suspicious for SARS-CoV-2(1). Subsequently, a larger series of 2428 patients presenting with new onset anosmia during the COVID-19 pandemic has been reported, of whom 16% report loss of sense of smell as an isolated symptom. Only 51% reported the recognized symptoms of cough or fever. A major limitation of this series however, was a lack of access to testing to confirm the COVID-19 status of the patients(2); in the 80 who had been tested 74% were positive. In the same way, the American Academy of Otolaryngology-head and neck surgery (AA0-HNS) proposed \"that anosmia could be added to the list of screening tools for possible COVID-19 infection. More, they warrant serious consideration for self-isolation and testing those patients&quot;.","Rhinology","Lechien, J R","Hopkins, C","Saussez, S","32352450"],"abstract":["Since the outbreak of the pandemic, anecdotal observations have been accumulating rapidly that sudden anosmia and dysgeusia are peculiar symptoms associated with the COVID-19 infection. Prof C. Hopkins, as President of British Rhinological Society, published a letter describing \"the loss of sense of smell as a marker of COVID-19 infection\" and proposed that adults presenting with anosmia but no other symptoms should self-isolate for seven days. The Hopkins team published the first case report and case series as well as other evidence that isolated sudden onset anosmia (ISOA), should be considered highly suspicious for SARS-CoV-2(1). Subsequently, a larger series of 2428 patients presenting with new onset anosmia during the COVID-19 pandemic has been reported, of whom 16% report loss of sense of smell as an isolated symptom. Only 51% reported the recognized symptoms of cough or fever. A major limitation of this series however, was a lack of access to testing to confirm the COVID-19 status of the patients(2); in the 80 who had been tested 74% were positive. In the same way, the American Academy of Otolaryngology-head and neck surgery (AA0-HNS) proposed \"that anosmia could be added to the list of screening tools for possible COVID-19 infection. More, they warrant serious consideration for self-isolation and testing those patients&quot;."],"journal":"Rhinology","authors":["Lechien, J R","Hopkins, C","Saussez, S"],"date":"2020-05-01T11:00:00Z","year":2020,"_id":"32352450","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.4193/Rhin20.159","topics":["Prevention","Diagnosis"],"weight":1,"_version_":1666138495667666944,"score":232.45265},{"pmid":32378854,"title":"Loss of smell or taste as the only symptom of COVID-19.","text":["Loss of smell or taste as the only symptom of COVID-19.","BACKGROUND: Olfactory and taste disorders (OTDs) have recently been reported among patients with COVID-19, and it has been hypothesised that oral and nasal tissues may contain host cells of SARS-CoV-2. We report on two cases (spouses) with SARS-CoV-2 infection with self-reported OTDs, but otherwise no typical respiratory symptoms of COVID-19. CASE PRESENTATION: A man in his nineties (index patient) had respiratory symptoms and dysgeusia, and was diagnosed with COVID-19. His daughter-in-law and son had no respiratory COVID-19 symptoms. However, they experienced complete loss of smell and taste, respectively, 7 and 10 days after their first close contact with the index patient. Both tested positive for SARS-CoV-2 RNA. INTERPRETATION: Our case histories support recent reports hypothesising that anosmia and ageusia may be the only symptoms of SARS-CoV-2 infection, and that SARS-CoV-2 may infect oral and nasal tissues. Together, these findings may inform future research, diagnosis, prevention and treatment of COVID-19.","Tidsskr Nor Laegeforen","Hjelmesaeth, Joran","Skaare, Dagfinn","32378854"],"abstract":["BACKGROUND: Olfactory and taste disorders (OTDs) have recently been reported among patients with COVID-19, and it has been hypothesised that oral and nasal tissues may contain host cells of SARS-CoV-2. We report on two cases (spouses) with SARS-CoV-2 infection with self-reported OTDs, but otherwise no typical respiratory symptoms of COVID-19. CASE PRESENTATION: A man in his nineties (index patient) had respiratory symptoms and dysgeusia, and was diagnosed with COVID-19. His daughter-in-law and son had no respiratory COVID-19 symptoms. However, they experienced complete loss of smell and taste, respectively, 7 and 10 days after their first close contact with the index patient. Both tested positive for SARS-CoV-2 RNA. INTERPRETATION: Our case histories support recent reports hypothesising that anosmia and ageusia may be the only symptoms of SARS-CoV-2 infection, and that SARS-CoV-2 may infect oral and nasal tissues. Together, these findings may inform future research, diagnosis, prevention and treatment of COVID-19."],"journal":"Tidsskr Nor Laegeforen","authors":["Hjelmesaeth, Joran","Skaare, Dagfinn"],"date":"2020-05-08T11:00:00Z","year":2020,"_id":"32378854","source":"PubMed","week":"202019|May 04 - May 10","doi":"10.4045/tidsskr.20.0287","topics":["Case Report"],"weight":1,"_version_":1666597097305014272,"score":190.6741},{"pmid":32340555,"title":"COVID-19 Anosmia Reporting Tool: Initial Findings.","text":["COVID-19 Anosmia Reporting Tool: Initial Findings.","There is accumulating anecdotal evidence that anosmia and dysgeusia are associated with the COVID-19 pandemic. To investigate their relationship to SARS-CoV2 infection, the American Academy of Otolaryngology-Head and Neck Surgery developed the COVID-19 Anosmia Reporting Tool for Clinicians for the basis of this pilot study. This tool allows health care providers to confidentially submit cases of anosmia and dysgeusia related to COVID-19. We analyzed the first 237 entries, which revealed that anosmia was noted in 73% of patients prior to COVID-19 diagnosis and was the initial symptom in 26.6%. Some improvement was noted in 27% of patients, with a mean time to improvement of 7.2 days in this group (85% of this group improved within 10 days). Our findings suggest that anomia can be a presenting symptom of COVID-19, consistent with other emerging international reports. Anosmia may be critical in timely identification of individuals infected with SARS-CoV2 who may be unwittingly transmitting the virus.","Otolaryngol Head Neck Surg","Kaye, Rachel","Chang, C W David","Kazahaya, Ken","Brereton, Jean","Denneny, James C 3rd","32340555"],"abstract":["There is accumulating anecdotal evidence that anosmia and dysgeusia are associated with the COVID-19 pandemic. To investigate their relationship to SARS-CoV2 infection, the American Academy of Otolaryngology-Head and Neck Surgery developed the COVID-19 Anosmia Reporting Tool for Clinicians for the basis of this pilot study. This tool allows health care providers to confidentially submit cases of anosmia and dysgeusia related to COVID-19. We analyzed the first 237 entries, which revealed that anosmia was noted in 73% of patients prior to COVID-19 diagnosis and was the initial symptom in 26.6%. Some improvement was noted in 27% of patients, with a mean time to improvement of 7.2 days in this group (85% of this group improved within 10 days). Our findings suggest that anomia can be a presenting symptom of COVID-19, consistent with other emerging international reports. Anosmia may be critical in timely identification of individuals infected with SARS-CoV2 who may be unwittingly transmitting the virus."],"journal":"Otolaryngol Head Neck Surg","authors":["Kaye, Rachel","Chang, C W David","Kazahaya, Ken","Brereton, Jean","Denneny, James C 3rd"],"date":"2020-04-29T11:00:00Z","year":2020,"_id":"32340555","source":"PubMed","week":"202018|Apr 27 - May 03","doi":"10.1177/0194599820922992","keywords":["covid-19","anosmia","coronavirus","dysgeusia","smell","taste"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1666138495037472770,"score":181.97623},{"pmid":32314436,"title":"Comment on \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S.","text":["Comment on \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S.","Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), patients with COVID-19 mainly present with fever and respiratory symptoms (2). Isolated sudden onset anosmia has also frequently been reported (3). Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations (4), we read with interest an initial study on the topic entitled \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S. (5).","J Eur Acad Dermatol Venereol","Hedou, M","Carsuzaa, F","Chary, E","Hainaut, E","Cazenave-Roblot, F","Masson Regnault, M","32314436"],"abstract":["Since the coronavirus disease 2019 (COVID 19) outbreak was first reported in the Chinese city of Wuhan on December 31, 2019, it has stricken more than 1,000,000 persons worldwide, of whom over 50,000 have died (1). Having been infected by severe acute respiratory syndrome coronavirus 2 (SARS-COV-2), patients with COVID-19 mainly present with fever and respiratory symptoms (2). Isolated sudden onset anosmia has also frequently been reported (3). Less frequently, rhinorrhea, diarrhoea and dysgeusia may be associated. While only a few reports have evoked cutaneous manifestations (4), we read with interest an initial study on the topic entitled \"Cutaneous manifestations in COVID-19: a first perspective \" by Recalcati S. (5)."],"journal":"J Eur Acad Dermatol Venereol","authors":["Hedou, M","Carsuzaa, F","Chary, E","Hainaut, E","Cazenave-Roblot, F","Masson Regnault, M"],"date":"2020-04-22T11:00:00Z","year":2020,"_id":"32314436","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1111/jdv.16519","keywords":["covid-19 infections","cutaneous manifestations","skin"],"locations":["Chinese","Wuhan"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis"],"weight":1,"_version_":1666138493420568576,"score":181.65933},{"pmid":32461325,"title":"Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.","text":["Anosmia and dysgeusia associated with SARS-CoV-2 infection: an age-matched case-control study.","BACKGROUND: Anosmia and dysgeusia have been reported as potential symptoms of coronavirus disease 2019. This study aimed to confirm whether anosmia and dysgeusia are specific symptoms among those who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: We conducted an age-matched case-control study in the Eastern Townships region of Quebec between Mar. 10 and Mar. 23, 2020. We included adults (age >/= 18 yr) who tested positive for SARS-CoV-2 by reverse transcription polymerase chain reaction. Cases were matched (1:1) according to 5-year age groups with control patents selected randomly from among all patients who tested negative for SARS-CoV-2 during the same period. Demographic and laboratory information was collected from medical records. Clinical symptoms and comorbidities associated with anosmia and dysgeusia were obtained by telephone interview with a standardized questionnaire. RESULTS: Among 2883 people tested for SARS-CoV-2, we identified 134 positive cases (70 women [52.2%] and 64 men [47.8%]; median age 57.1 [interquartile range 41.2-64.5] yr). The symptoms independently associated with SARS-CoV-2 positivity in conditional logistic regression were anosmia or dysgeusia or both (adjusted odds ratio [OR] 62.9, 95% confidence interval [CI] 11.0-359.7), presence of myalgia (adjusted OR 7.6, 95% CI 1.9-29.9), blurred vision (adjusted OR 0.1, 95% CI 0.0-0.8) and chest pain (adjusted OR 0.1, 95% CI 0.0-0.6). INTERPRETATION: We found a strong association between olfactory and gustatory symptoms and SARS-CoV-2 positivity. These symptoms should be considered as common and distinctive features of SARS-CoV-2 infection and should serve as an indication for testing and possible retesting of people whose first test result is negative.","CMAJ","Carignan, Alex","Valiquette, Louis","Grenier, Cynthia","Musonera, Jean Berchmans","Nkengurutse, Delphin","Marcil-Heguy, Anais","Vettese, Kim","Marcoux, Dominique","Valiquette, Corinne","Xiong, Wei Ting","Fortier, Pierre-Hughes","Genereux, Melissa","Pepin, Jacques","32461325"],"abstract":["BACKGROUND: Anosmia and dysgeusia have been reported as potential symptoms of coronavirus disease 2019. This study aimed to confirm whether anosmia and dysgeusia are specific symptoms among those who tested positive for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). METHODS: We conducted an age-matched case-control study in the Eastern Townships region of Quebec between Mar. 10 and Mar. 23, 2020. We included adults (age >/= 18 yr) who tested positive for SARS-CoV-2 by reverse transcription polymerase chain reaction. Cases were matched (1:1) according to 5-year age groups with control patents selected randomly from among all patients who tested negative for SARS-CoV-2 during the same period. Demographic and laboratory information was collected from medical records. Clinical symptoms and comorbidities associated with anosmia and dysgeusia were obtained by telephone interview with a standardized questionnaire. RESULTS: Among 2883 people tested for SARS-CoV-2, we identified 134 positive cases (70 women [52.2%] and 64 men [47.8%]; median age 57.1 [interquartile range 41.2-64.5] yr). The symptoms independently associated with SARS-CoV-2 positivity in conditional logistic regression were anosmia or dysgeusia or both (adjusted odds ratio [OR] 62.9, 95% confidence interval [CI] 11.0-359.7), presence of myalgia (adjusted OR 7.6, 95% CI 1.9-29.9), blurred vision (adjusted OR 0.1, 95% CI 0.0-0.8) and chest pain (adjusted OR 0.1, 95% CI 0.0-0.6). INTERPRETATION: We found a strong association between olfactory and gustatory symptoms and SARS-CoV-2 positivity. These symptoms should be considered as common and distinctive features of SARS-CoV-2 infection and should serve as an indication for testing and possible retesting of people whose first test result is negative."],"journal":"CMAJ","authors":["Carignan, Alex","Valiquette, Louis","Grenier, Cynthia","Musonera, Jean Berchmans","Nkengurutse, Delphin","Marcil-Heguy, Anais","Vettese, Kim","Marcoux, Dominique","Valiquette, Corinne","Xiong, Wei Ting","Fortier, Pierre-Hughes","Genereux, Melissa","Pepin, Jacques"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32461325","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1503/cmaj.200869","locations":["Quebec","myalgia"],"countries":["Canada"],"countries_codes":["CAN|Canada"],"topics":["Diagnosis"],"weight":1,"_version_":1668079521434173440,"score":178.72893}]}